| Patient | Nikola Tesla |
|---|---|
| Date of birth | 1980-07-10 |
| Identifiers | MRN HR-NI009-SYN; SSN (made up) 000-09-7408 |
| Document date | 2026-11-01 |
| Author | Branimir Kovač-Holt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New-patient primary care visit for counting, washing, and food rituals that are taking hours each day, with weight loss and sore hands. Concerns: Counting, calculating, and repeating everything in threes now takes hours each day and is slowing his work just when his largest project needs him; Fear of dirt and germs: he washes his hands dozens of times a day until they crack, wipes cutlery before he eats, and avoids shaking hands; Meals take so long to calculate that he skips them, and he has lost weight; he sleeps about four hours a night. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-01-13 to 2026-02-24 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-02-24 to 2026-04-07 | completed | S |
| Sertraline 50 mg oral tablet, three tablets (150 mg) by mouth each morning | Three tablets by mouth each morning | Oral route | 2026-04-07 | active | S |
| White petrolatum ointment, apply to both hands after each wash and at bedtime | Apply a thin layer to both hands after washing and at bedtime | Topical route | 2026-01-13 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Advance care planning conversation, about 20 minutes | 2026-10-13 to 2026-10-13 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2025-10-20 | Influenza vaccine, 2025-2026 season | completed | S |
| 2019-03-12 | Tdap vaccine | completed | S |
| 2026-10-13 | Influenza vaccine, 2026-2027 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| Childhood | Aversions (pearls, women's earrings, touching other people's hair), counting steps, calculating the volume of food before eating, and repeating acts in multiples of three, as he later described them | D (CLM-0003, CLM-0004) |
| About age twelve | Vivid involuntary images with flashes of light that caused him discomfort and anxiety; learned to banish the images at about twelve | D (CLM-0002) |
| About 1873 | Cholera at seventeen | D (CLM-0006) |
| 1881 | Severe illness in Budapest that he called a complete breakdown of the nerves, with extreme sensitivity to sound and light, tremor, and a racing pulse; recovered | D (CLM-0007) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| Counting, calculating, and repeating everything in threes now takes hours each day and is slowing his work just when his largest project needs him | active | S |
| Fear of dirt and germs: he washes his hands dozens of times a day until they crack, wipes cutlery before he eats, and avoids shaking hands | active | S |
| Meals take so long to calculate that he skips them, and he has lost weight; he sleeps about four hours a night | active | S |
Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 2026-10-13; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 on 2026-06-30; Total score [AUDIT-C] 1 on 2026-10-13; Sodium [Moles/volume] in Serum or Plasma 138 on 2026-01-13; Potassium [Moles/volume] in Serum or Plasma 4.1 on 2026-01-13; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 2026-01-13; Urea nitrogen [Mass/volume] in Serum or Plasma 11 on 2026-01-13; Creatinine [Mass/volume] in Serum or Plasma 0.82 on 2026-01-13; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 110 on 2026-01-13; Glucose [Mass/volume] in Serum or Plasma 81 on 2026-01-13; Albumin [Mass/volume] in Serum or Plasma 4.2 on 2026-06-30; Hemoglobin [Mass/volume] in Blood 13.4 on 2026-01-13; Thyrotropin [Units/volume] in Serum or Plasma 2.2 on 2026-01-13; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 412 on 2026-06-30; Cholesterol [Mass/volume] in Serum or Plasma 176 on 2026-10-13; Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 on 2026-10-13; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 102 on 2026-10-13; Triglyceride [Mass/volume] in Serum or Plasma 78 on 2026-10-13 [S]
Strengths and supports: Supports: his work and its purpose, two long-serving engineers on his staff, and a long walk each day; no firearms in the home [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Obsessive-compulsive disorder, severe (Y-BOCS 28), with good insight: contamination, symmetry, and number obsessions; washing, counting, repeating in threes, and calculating compulsions; synthetic modern diagnosis linked to his own accounts of counting and calculating rituals and aversions | active | confirmed | F42.2 | S — Synthetic modern diagnosis. His rituals and aversions are documented in his own words (D); calling them obsessive-compulsive disorder is a retrospective interpretation (R), and no diagnosis was made in his lifetime. |
| Irritant contact dermatitis of both hands from washing them 40 to 60 times a day | resolved | confirmed | L24.9 | S — Synthetic consequence of washing compulsions. |
| Underweight (BMI 18.1) with about 4 kg weight loss over six months, from skipped meals and food-calculating rituals | resolved | confirmed | R63.6 | S — Synthetic nutritional consequence echoing his documented habit of calculating the volume of food before eating. |
| Insufficient sleep, four hours a night, from late work and night-time rituals | resolved | confirmed | Z72.820 | S — Synthetic sleep problem echoing his documented claims about very short sleep. |
| Acute viral gastroenteritis, probably norovirus, with mild dehydration; resolved | resolved | confirmed | A08.4 | S — Synthetic acute illness at an unscheduled visit, chosen to teach rehydration, sertraline during vomiting, antiemetic interactions, and infection-control advice that does not feed contamination rituals; it does not echo any documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-01-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 12 | {score} | S | ||
| 2026-01-13 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 2026-01-13 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-01-13 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-01-13 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-01-13 | Urea nitrogen [Mass/volume] in Serum or Plasma | 11 | mg/dL | 6-21 mg/dL | Normal | S |
| 2026-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.82 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-01-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 110 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-01-13 | Glucose [Mass/volume] in Serum or Plasma | 81 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-13 | Albumin [Mass/volume] in Serum or Plasma | 3.8 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-01-13 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-01-13 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 2026-01-13 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 284 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-02-24 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 2026-02-24 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 10 | {score} | S | ||
| 2026-06-30 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-06-30 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 2026-06-30 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 412 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-06-30 | Albumin [Mass/volume] in Serum or Plasma | 4.2 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-10-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 2026-10-13 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 2026-10-13 | Cholesterol [Mass/volume] in Serum or Plasma | 176 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-10-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-10-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 102 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-10-13 | Triglyceride [Mass/volume] in Serum or Plasma | 78 | mg/dL | <=149 mg/dL | Normal | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-13 | Body height | 188 | cm | S |
| 2026-01-13 | Body weight | 63.8 | kg | S |
| 2026-01-13 | Body mass index (BMI) [Ratio] | 18.1 | kg/m2 | S |
| 2026-01-13 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-01-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-01-13 | Heart rate | 74 | /min | S |
| 2026-01-13 | Respiratory rate | 14 | /min | S |
| 2026-01-13 | Body temperature | 36.5 | Cel | S |
| 2026-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-01-27 | Body height | 188 | cm | S |
| 2026-01-27 | Body weight | 63.9 | kg | S |
| 2026-01-27 | Body mass index (BMI) [Ratio] | 18.1 | kg/m2 | S |
| 2026-01-27 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-01-27 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-01-27 | Heart rate | 72 | /min | S |
| 2026-01-27 | Respiratory rate | 14 | /min | S |
| 2026-01-27 | Body temperature | 36.6 | Cel | S |
| 2026-01-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-02-24 | Body height | 188 | cm | S |
| 2026-02-24 | Body weight | 64.6 | kg | S |
| 2026-02-24 | Body mass index (BMI) [Ratio] | 18.3 | kg/m2 | S |
| 2026-02-24 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-02-24 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-02-24 | Heart rate | 70 | /min | S |
| 2026-02-24 | Respiratory rate | 14 | /min | S |
| 2026-02-24 | Body temperature | 36.5 | Cel | S |
| 2026-02-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-04-07 | Body height | 188 | cm | S |
| 2026-04-07 | Body weight | 65.2 | kg | S |
| 2026-04-07 | Body mass index (BMI) [Ratio] | 18.4 | kg/m2 | S |
| 2026-04-07 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-04-07 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-04-07 | Heart rate | 68 | /min | S |
| 2026-04-07 | Respiratory rate | 14 | /min | S |
| 2026-04-07 | Body temperature | 36.6 | Cel | S |
| 2026-04-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-06-30 | Body height | 188 | cm | S |
| 2026-06-30 | Body weight | 66.9 | kg | S |
| 2026-06-30 | Body mass index (BMI) [Ratio] | 18.9 | kg/m2 | S |
| 2026-06-30 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-06-30 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-06-30 | Heart rate | 66 | /min | S |
| 2026-06-30 | Respiratory rate | 14 | /min | S |
| 2026-06-30 | Body temperature | 36.6 | Cel | S |
| 2026-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-08-11 | Body height | 188 | cm | S |
| 2026-08-11 | Body weight | 65.9 | kg | S |
| 2026-08-11 | Body mass index (BMI) [Ratio] | 18.6 | kg/m2 | S |
| 2026-08-11 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-08-11 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-08-11 | Heart rate | 92 | /min | S |
| 2026-08-11 | Respiratory rate | 16 | /min | S |
| 2026-08-11 | Body temperature | 37.8 | Cel | S |
| 2026-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-13 | Body height | 188 | cm | S |
| 2026-10-13 | Body weight | 67.4 | kg | S |
| 2026-10-13 | Body mass index (BMI) [Ratio] | 19.1 | kg/m2 | S |
| 2026-10-13 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-10-13 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-10-13 | Heart rate | 64 | /min | S |
| 2026-10-13 | Respiratory rate | 14 | /min | S |
| 2026-10-13 | Body temperature | 36.6 | Cel | S |
| 2026-10-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-01-13 | New-patient primary care visit for counting, washing, and food rituals that are taking hours each day, with weight loss and sore hands | finished | S |
| 2026-01-27 | Two-week sertraline tolerability and safety check, with psychiatry consultation | finished | S |
| 2026-02-24 | Six-week OCD treatment review | finished | S |
| 2026-04-07 | Twelve-week OCD treatment review | finished | S |
| 2026-06-30 | Twenty-four-week OCD treatment review | finished | S |
| 2026-08-11 | Same-day sick visit for vomiting and diarrhea | finished | S |
| 2026-10-13 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Structured assessment: Y-BOCS symptom checklist and severity scale, PHQ-9, GAD-7, and AUDIT-C today; interview for tics, bipolar disorder, psychosis, hoarding, and body dysmorphic symptoms; thyroid, blood count, metabolic panel, albumin, and vitamin B12 for weight loss | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Psychiatry consultation to confirm the diagnosis, review comorbidity, and advise on sertraline dosing and the length of the trial | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Exposure and response prevention with the clinic psychologist, weekly for 16 to 20 sessions, with a hierarchy he builds himself (touching door handles, shaking hands, eating without calculating, doing things in numbers other than three) and homework between sessions | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Start sertraline 50 mg each morning; if the response is inadequate after four to six weeks, raise it in 50 mg steps every four to six weeks as tolerated, up to 200 mg, warning him about side effects and checking for them after each increase; judge the response only after eight to twelve weeks with at least four to six weeks at the top tolerated dose; continue for one to two years after a response | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; suicide-risk review at every visit | completed | GL-SUICIDE-2024 | S |
| Nutrition: three fixed mealtimes, energy-dense foods he accepts, a session with the clinic dietitian, and weight at every visit; eating without calculating is an exposure target, not a rule imposed at the table | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Hands: petrolatum after each wash and at night, cotton gloves overnight, nitrile gloves for laboratory solvents; cutting down washing is part of the exposure work | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Sleep: a fixed six-to-seven-hour sleep window, no laboratory work after midnight, and a sleep diary | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Respectful examination: explain each step and ask before touching; offer hand sanitizer, gloves, and paper covers before and after; let him wash if he wishes; no handshake expected; no unplanned exposures in clinic, which belong in therapy | completed | GL-APA-OCD-2007, GL-APA-OCD-2013, GL-NICE-CG31 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Y-BOCS down by at least 35 percent (treatment response) by twenty-four weeks | 2026-06-30 | completed | Y-BOCS 13 at twenty-four weeks, down 54 percent from 28 | S |
| Rituals under one hour a day, with meals eaten without calculating | 2026-06-30 | completed | Rituals about 45 minutes a day; most meals eaten without calculation | S |
| BMI at least 18.5 with three meals a day | 2026-06-30 | completed | Weight 66.9 kg, BMI 18.9 | S |
| Hands healed, with washing under 15 times a day | 2026-04-07 | completed | Skin healed; washing about 12 times a day by twelve weeks | S |
| At least six hours of sleep most nights | 2026-06-30 | completed | About six hours most nights | S |
Structured synthetic safety assessment on 2026-01-13: current ideation absent, intent absent, plan absent. Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, and a two-week follow-up [S]